NEIDL Researchers Collaborate on AI-Driven Approach to Identify Potential New Ebola Drug Targets
NEIDL researchers have found a new method to identify human genes that, when silenced, impair the Ebola virus’s ability to infect host cells.
NEIDL Researcher Quoted In Washington Post on H5N1
The recent bird flu outbreak is being regarded as the largest animal disease outbreak on record, raising concerns about its potential to spark a pandemic.
NEIDL Researcher Florian Douam, PhD, Receives Smith Family Foundation’s Odyssey Award
Two junior faculty members have been awarded Smith Family Foundation’s…
NEIDL Researcher Wins a 2024 Kilachand Fund Award
What if we could find a way to bring mRNA vaccines and antibodies together, so each retains their benefits while reducing their limitations? A new Boston University project aims to do just that.
BU’s Leading Home for Infectious Diseases Research to Get Major Upgrade with NIH Grant
One of just two National Biocontainment Laboratories in the United States, the NEIDL has just been given a $7.5 million grant from the National Institutes of Health to modernize its facilities and help broaden its impact.
NEIDL Awarded $7.5 Million Construction Grant
We are excited to announce that the NEIDL successfully competed for a $7.5 million construction grant (C06) from the National Institutes of Health (NIH). This generous funding will be crucial in expanding the NEIDL’s capabilities to address both current and future research needs.
A New Type of RNA Could Revolutionize Vaccines and Cancer Treatments
An accidental discovery turned into an unexpected success, when a team of interdisciplinary BU researchers created a new and improved COVID vaccine.
Modified Self-Amplifying RNA Provides Opportunities For New Vaccines And Treatments
A paper published on July 8, 2024 in the journal Nature Biotechnology presents promising data that offers a foundation for developing future vaccines and treatments.
After 30 years of decline, tuberculosis is rising in the U.S. again. How did we get here?
After declining for three decades, tuberculosis (TB) rates in the U.S. have been increasing steadily since 2020.
Is COVID-19 Still a Pandemic?
The Brink asked three Boston University researchers—a virologist, an epidemiologist, and an emergency room physician—to explain the shifting status of COVID, how to decide when a virus has gone from a pandemic to endemic, how much people should protect themselves and others, and why language matters.